Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Signs MOU with Taiwan ITRI

6 Aug 2007 07:00

ViaLogy PLC06 August 2007 Date: 6 August 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") Embargoed until: 0700hrs ViaLogy plc Signs Memorandum of Understanding with Taiwan's Industrial Technology Research Institute London, 6 August, 2007 - ViaLogy plc (LSE: VIY), a leading innovator ofreal-time network-centric signal processing platforms, today announces that ithas signed a memorandum of understanding (MOU) with Taiwan's IndustrialTechnology Research Institute (ITRI) to integrate its products, SPMTM andMicroSPMTM, with sensor systems developed by ITRI spin-out companies for uses insafety, security, surveillance and infrastructure management. SPMTM provides a standards-based, sensor-policy engine for managing large-scalenetworks of distributed sensors and systems, including building managementsystems, energy planning and physical security. SPM software allows automatedanalysis, alerting of appropriate personnel and rapid response. MicroSPMTMoffers a high speed hardware platform for fully-autonomous incident-based rapiddetection, analysis and response for sensor and video processing. Using thistechnology, ITRI's products can be enabled to interact rapidly with othernetworked subsystems which support a range of communication protocols. Founded in 1973, ITRI has played a vital role in Taiwan's economic success.Notable ITRI spin-off companies include United Microelectronics Corporation(UMC), the Taiwan Semiconductor Manufacturing Corporation (TSMC), and theVanguard International Semiconductor Company (VIS). Backed by its broadresearch scope and close industrial ties, ITRI is a leader in the globalindustrial R&D community. ITRI has signed research alliances with leadingforeign companies and universities such as Lucent Technologies, Microsoft, MITand the University of California, Berkeley. Michael Kelly, President and CEO of ViaLogy's US subsidiary, commented: "Thiscollaboration is a strategic one for ViaLogy. ITRI has a reputation forcreatively adapting foreign industrial processes to address identified needs andusing these technologies to help its spin-out companies become competitive inworld markets. In today's knowledge-based economy, we believe this cooperationwith ITRI will help position SPM as a comprehensive sensor interoperabilitysolution and service delivery platform for various industries and applicationsacross Asia." Dr. John Mai, ViaLogy's Manager for RFID Platforms, said: "ITRI hasrelationships with the major technology-related businesses in Taiwan. Thiscollaboration will accelerate adoption of SPMTM for large-scale industrialapplications. We are already working on integrating innovative sensor solutionsbeing developed at ITRI to quickly expand and scale up its installed-user base." Dr. Wu Chi Ho, Director of the Power Control and Sensing Application TechnologyDivision, of the Energy and Environmental Research Laboratories within ITRI,commented: "We believe ViaLogy's SPMTM and MicroSPMTM platforms presentexciting solutions to fill gaps in our development and commercialisationprocess. Their IP-enabled sensor interoperability software offers us a path torapidly bring our infrastructure monitoring projects to enterprise-level endusers in the oil and energy market sectors, both within Taiwan andinternationally. "ViaLogy's ability to add new sensors and support new network interoperabilityprotocols within 72 hours is very attractive for our scaling requirements." For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy +44 (0)20 107 8000 About ITRI: The Industrial Technology Research Institute of Taiwan ITRI is a global, non-profit R&D organisation, engaged in applied research andindustrial services. Founded in 1973, ITRI played a vital role in Taiwan'seconomic success and is leading industrial research to transform Taiwan'seconomy from a manufacturing-based one to that of service- and knowledge- based.Backed by its broad research scope and close industrial ties, ITRI is becomingan increasingly active member in the global industrial R&D community. About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Feb 20177:00 amRNSSouthern Europe Business Update
10th Jan 20173:33 pmRNSResult of General Meeting
10th Jan 20177:15 amRNSHardman Research: Yourgene improves growth
21st Dec 20164:00 pmRNSPosting of Circular
21st Dec 20167:00 amRNSHalf year results
21st Dec 20167:00 amRNSConditional Acquisition of Yourgene Bioscience
21st Nov 20167:00 amRNSPremaitha establishes first service lab in Asia
31st Oct 20167:00 amRNSPremaitha welcomes UK Govt. decision on NIPT
27th Oct 20164:10 pmRNSResult of AGM
27th Oct 20167:00 amRNSAGM Statement
21st Oct 20167:00 amRNSGrant of Options
3rd Oct 20167:15 amRNSHardman Research: Excellent first year for IONA®
30th Sep 20163:38 pmRNSNotice of AGM
30th Sep 20167:00 amRNSFinal Results
23rd Sep 201610:42 amRNSHolding(s) in Company
23rd Sep 20168:50 amRNSNotice of results & appointment of broker
23rd Sep 20168:50 amRNSInvestment agreement extension with Thermo Fisher
8th Sep 20169:08 amRNSDirectorate Change
6th Jul 20167:00 amRNSDirectorate Change
4th Jul 20167:00 amRNSProgress on anti-trust objections to litigation
22nd Jun 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
22nd Apr 201610:45 amRNSUpdate on competitor patent litigation
20th Apr 201611:14 amRNSHardman Research: IONA sales & litigation update
20th Apr 20167:00 amRNSPatent Litigation Rescheduled
18th Apr 20161:13 pmRNSHardman & Co Issues Research Report
18th Apr 20161:03 pmRNSHardman & Co Issues Research Report
14th Apr 20167:00 amRNSHolding(s) in Company
13th Apr 20169:52 amRNSHolding(s) in Company
13th Apr 20167:00 amRNSHoldings in Company, Director's Shareholding
11th Apr 20167:00 amRNSTrading Update
29th Mar 20167:00 amRNSPremaitha announces tenth customer laboratory
21st Mar 20167:00 amRNSDistribution Agreements in the Middle East
9th Mar 20165:21 pmRNSHolding in Company, Directors' Dealing Replacement
9th Mar 20163:33 pmRNSHolding in Company, Directors' Dealings
9th Mar 20167:00 amRNSDistribution Agreement with GeNext - Russia
7th Mar 20167:00 amRNSAppointment of Joint Broker
3rd Feb 20167:00 amRNSPremaitha partners with Visional Medical in India
2nd Feb 20167:00 amRNSPremaitha partners with Leeds Hospitals NHS Trust
28th Jan 20167:00 amRNSHardman & Co Research Report: IONA®-Up and running
27th Jan 20167:00 amRNSTwo new customers signed for clinical lab service
26th Jan 20162:29 pmRNSUpdate on UK Litigation Timing
15th Jan 20167:00 amRNSPremaitha welcomes NSC recommendation on NIPT
8th Jan 201612:40 pmRNSUpdate on competitor patent litigation
18th Dec 20157:00 amRNSDirector/PDMR Shareholding
16th Dec 20155:53 pmRNSHolding(s) in Company
15th Dec 20157:00 amRNSHardman Issues Research Report
14th Dec 20157:00 amRNSInvestment Agreement with Thermo Fisher Scientific
14th Dec 20157:00 amRNSHalf Yearly Report
11th Dec 20157:00 amRNSNotice of Half Year Results
2nd Dec 20157:00 amRNSFirst IONA® testing service in France at LaboSud

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.